Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Patients report significant weight loss with compounded semaglutide that would be difficult to maintain if forced to discontinue treatment due to cost barriers, despite manufacturer discount programs reducing brand-name medication costs to approximately $499 monthly.
Clinical Pharmacology May 1st 2025
Medical News Today (MNT)
Claims that semaglutide microdosing works to maintain weight loss and manage blood sugar are mainly anecdotal and not backed by scientific research.
Clinical Pharmacology April 9th 2025
MDLinx
“It isn’t easy to kick this… Because porn shrinks your world.” —Aline Zoldbrod, PhD
Family Medicine/General Practice April 1st 2025
Verywell Health
“It’s absolutely not nature’s Ozempic and does not work like Ozempic, which is a GLP-1 inhibitor. Manufacturers of these supplements are just kind of creating a hype…”
Clinical Pharmacology March 31st 2025
“We are recommending that if patients are starting these drugs or increasing the dose of these drugs, they should do so slowly to reduce the risk of dropping their blood sugar and causing an osmotic shift.”
Endocrinology, Diabetes, Metabolism February 21st 2025
Women’s Healthcare
The study demonstrated a reduced risk of suicidal thoughts and self-harm among people using GLP-1 drugs.
Clinical Pharmacology February 11th 2025